SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Aug 13, 2014
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Aug. 13, 2014 · CIK: 0001279704 · Accession: 0001144204-14-049451
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-196091
Letter
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
August 13, 2014
Via EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1,
File No. 333-196091
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-196091), as amended, be accelerated so that the Registration Statement will become effective at 5:00 p.m. on August 14, 2014, or as soon as practicable thereafter.
The Company hereby acknowledges that:
(a) should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any other action with respect to the filing;
(b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(c) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
August 13, 2014
Via EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1,
File No. 333-196091
Ladies and Gentlemen:
Pursuant to Rule 461(a)
under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”),
hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-196091),
as amended, be accelerated so that the Registration Statement will become effective at 5:00 p.m. on August 14, 2014, or as soon
as practicable thereafter.
The Company hereby acknowledges
that:
(a) should the Commission or the staff, acting pursuant to delegated authority, declare the Registration
Statement effective, it does not foreclose the Commission from taking any other action with respect to the filing;
(b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the
filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in
the filing; and
(c) the Company may not assert staff comments and the declaration of effectiveness as a defense in any
proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By: /s/ Simon Pedder
Simon Pedder, President and Chief Executive Officer